| Covariate | Unadjusted model | Adjusted model | ||
| HR (95% CI) | p-value | HR (95% CI) | p-value | |
| Age | 1.03 (1.02; 1.05) | <0.001 | 1.04 (1.03; 1.06) | <0.001 |
| Gender |
|
|
|
|
| Male-ref. | 1 |
| 1 |
|
| Female | 0.78 (0.60; 1.01) | 0.058 | 0.87 (0.66; 1.15) | 0.321 |
| Comorbidity |
|
|
|
|
| No-ref. | 1 |
| 1 |
|
| Yes | 1.29 (0.99; 1.68) | 0.062 | 1.16 (0.86; 1.55) | 0.332 |
| Mode of presentation |
|
|
|
|
| Emergency | 2.18 (1.19; 3.99) | 0.012 | 1.62 (0.83; 3.17) | 0.161 |
| Planned-ref. | 1 |
| 1 |
|
| Type of surgery |
|
|
|
|
| Hartmann | 1.05 (0.59; 1.88) | 0.870 | 0.58 (0.30; 1.14) | 0.112 |
| Low Anterior Resection | 0.71 (0.54; 0.93) | 0.013 | 0.65 (0.47; 0.91) | 0.011 |
| Abdominoperineal res.-ref. | 1 |
| 1 |
|
| Tumour fixation |
|
|
|
|
| No-ref. | 1 |
| 1 |
|
| Yes | 1.55 (1.04; 2.32) | 0.032 | 1.20 (0.74; 1.92) | 0.462 |
| Lymph node dissection |
|
|
|
|
| No mesorectal excision-ref. | 1 |
| 1 |
|
| PME | 0.84 (0.58; 1.22) | 0.356 | 0.92 (0.61; 1.41) | 0.714 |
| TME | 0.64 (0.47; 0.87) | 0.004 | 0.69 (0.50; 0.95) | 0.024 |
| Unknown | 0.82 (0.54; 1.26) | 0.369 | 0.91 (0.58; 1.44) | 0.685 |
| Perforation |
|
|
|
|
| No perforation | 1 |
| 1 |
|
| Pre/perioperative perforation | 1.96 (1.27; 3.01) | 0.002 | 1.22 (0.76; 1.96) | 0.407 |
| TNM-stage |
|
|
|
|
| Stage I-ref. | 1 |
| 1 |
|
| Stage II | 1.69 (1.13; 2.52) | 0.010 | 1.55 (1.00; 2.40) | 0.049 |
| Stage III | 2.91 (1.93; 4.40) | <0.001 | 2.95 (1.87; 4.67) | <0.001 |
| Stage IV | 9.19 (5.76; 14.67) | <0.001 | 1.23 (0.14; 10.77) | 0.851 |